![]() |
![]() |
|||||||||||||||||||||
|
|
||||||||||||||||||||||
|
|
|
|||||||||||||||||||||
|
|
||||||||||||||||||||||
ABSTRACT: Many studies have shown the relationship between an elevated intake of dietary saturated fats, high levels of total serum cholesterol and high mortality rates from atherosclerotic diseases. The mortality curve from ischemic heart disease was rising in Cuba until 1990, when it began to drop, finally reaching 25% of the peak value. The period of higher mortality was linked to high consumption of dietary saturated fats among the Cuban population, indicated by elevated total serum cholesterol levels. The drop began with the so-called "Special Period" in Cuba, corresponding to the country's economic crisis, and was characterized by a decreased intake of dietary saturated fats, a less sedentary lifestyle and a lower incidence of obesity in the Cuban population. Yet, the reduction in mortality rates from ischemic heart disease has been less than one would have expected from the decrease in total serum cholesterol levels. This may be the result of other as yet unidentified risk factors associated with atherosclerosis in the Cuban population. Background
Many observational, randomized studies--some of which were conducted 60 years ago--have shown the relationship between diet and mean levels of total serum cholesterol.1-8
Populations that consume high levels of dietary saturated fats and cholesterol have higher levels of serum lipids and cholesterol that those with low intakes of these elements.9,10
Epidemiological studies have shown that people with elevated levels of serum cholesterol have a higher risk of developing atherosclerosis than those with normal levels of serum cholesterol.3-5, 11
Moreover, a reduction in the levels of total serum cholesterol in a given population, due either to changes in lifestyle or to medical treatment, has been shown to decrease mortality rates from atherosclerosis-related disease.
12,13 Framingham14 demonstrated a linear correlation between decreased levels of serum cholesterol and mortality due to ischemic heart disease. In his study, a
reduction of 5 mg/dL in these levels over 6 years corresponded to a decrease of 4.3% in the mortality rate from this disease. Mortality Rate from Ischemic Heart Disease in Cuba Mortality rates from ischemic heart disease in Cuba from
1986 to 1997 (Fig. 1), show two markedly different tendencies: from 1986 to 1990,
In their work published in 1987, Ríos and Tejeiro reported five-year increases in calorie and protein consumption among the Cuban population since 1965.15
So strong was the impact of these events on the Cuban economy and on the health of the population that an outbreak of epidemic neuropathy affected nearly 50,000 people on the island between 1991 and 1993. Nutritional studies carried out between 1991 and 1995 showed that a significant portion of the Cuban population had diets low in fats and nutrients. Among these is the 1993 study carried out by Gay et al. on the Isle of Youth 16 of epidemic neuropathy patients compared to a control group, reporting the following findings:
A similar study was conducted by Cabrera et al.,17 in 1995, with a group of railway workers in Havana, in which the following findings were reported:
Comparing the levels of total serum cholesterol in the Cuban population before and after 1990, we refer to a 1988 survey carried out in Havana's 10 de Octubre Municipality (Dueñas A, et al., Unpublished Observations. Debs G. Tesis de Especialidad en Cardiología) showing that 29% of men and 37.7% of women had levels of total serum cholesterol higher than 5.2 mmol/L, with the mean at 5.29 mmol/L (204.6 mg/dL). However, a 1994 survey showed a mean level for total serum cholesterol at only 4.23 mmol/L (163.6 mg/dL). That is, we observe a decrease of 1.06 mmol/L (41 mg/dL) between the two periods studied. Cabrera, et al.17 also conducted a study between 1987 and 1988 on levels of serum lipids in railway workers, which revealed that 15.5% of men and 15.2% of women had levels of total serum cholesterol higher than 6.2 mmol/L (240 mg/dL). In 1995, the mean level of total serum cholesterol in the same population was 3.5 mmol/L in men and 3.34 mmol/L in women. These findings indicate that the period of increasing mortality from ischemic heart disease corresponded to a diet high in calories and with a mean total cholesterol at high risk levels; while the period of decreasing mortality was characterized by a diet low in fats, with a mean total cholesterol below risk levels. Nevertheless, according to the Framingham studies,13,14,18 such a low consumption of dietary fats (which decreased by 41 mg/dL) should have resulted not in a 36% reduction in mortality, and not the mere 25% as occurred in Cuba. So far, we have no explanation for this fact. In Cuba, as in other countries, a level of total serum cholesterol higher than 200 mg/dL is considered a risk factor for acute myocardial infarction. However, the FRICAS multinational study showed that in Cuba, 68.5% of cases with acute myocardial infarction had levels of total serum cholesterol lower than 200 mg/dL upon hospital admittance. The Cuban rates may have been influenced by the development of other risk factors. In 1995, in the 10 de Octubre Municipality (Dueñas A, et al., Unpublished Observations) the incidence of smoking, arterial hypertension, and diabetes mellitus remained almost unaltered from 1986 to 1997, although in recent years, the incidence of obesity and sedentary lifestyles have markedly decreased. The prevalence of other risk factors involved in the etiology and pathogenesis of ischemic heart disease, such as a deficit of antioxidants and hyper-homocysteinemia, has not yet been studied in Cuba.18 Conclusions
References 1. Cowdry EV, ed. Arteriosclerosis. New York: McMillan, 1993:1-246. 2. Johnson BC, Epstein FH, Kjelsberg MO. Distribution and familial studies of blood pressure and serum cholesterol levels in a total community. Tecumseh, Michigan. Chronic Dis 1965;18:147-60. 3. Stamler J, Wentworth D, Neaton JD for the MRFIT Group. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Finding in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256:2823-8. 4. Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results I. Reduction in incidence of coronary heart disease JAMA 1984;251:351-67. 5. Committee of Principal Investigators: a co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Br Heart J 1978;40:1069-78. 6. Frick MH, Elo O, Haapa K for the HHS. Helsinki Heart Study. Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987;317:1237-56. 7. Hjiermann I, Velve BK, Holme I, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease: Report from the Oslo Study Group of randomised trial in healthy men. Lancet 1981;2:1303-16. 8. Scandinavian Sinvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Sinvastatin Survival Study (4S). Lancet 1994;344:1383-92. 9. Keys A, ed. Coronary heart disease in seven countries. American Heart Association Monograph 29. Circulation 1970;41 (Suppl 1):1-129. 10. Robertson TL, Kato H, Rhoads GC. Epidemiological studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Incidence of myocardial infarction and death from coronary heart disease. Am J Cardiol 1977;39:239-56. 11. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) JAMA 1993;269:3015-64. 12. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991:83;356-63. 13. Farmer JA, Gotto AJR. Dyslipidemia and other risk factors for coronary artery disease. In: Braunwald E, ed. Disease of the Heart. 5 ed. Philadelphia: Saunders 1997. 14. Abraham S, Johnson CI, Carrol MD. A comparison of levels of serum cholesterol of adults 18-74 years of age in the United States in 1960-1972 and 1971-1974. Advanced data from vital and health statistics of the National Center for Health Statistics, U.S. DHEW No. 5:1-4, February 22, 1977. 15. Ríos E, Tejeiros A. Evolución de la mortalidad en Cuba analizando un trienio de cada década del período revolucionario. Rev Cubana Med Gen Integr 1987;3(Suplemento):65-83. 16. Gay J, Porrata C, Hernández M, Clúa AM, Arguelles JM, Cabrera A, et al. Factores dietéticos de la neuropatía epidémica en la Isla de la Juventud, Cuba. Bol Oficina Sanit Panam 1994;117:389-99. 17. Cabrera Hernández A, Jiménez Acosta A, Hernández Lozano MA, Quintero Alejo ME, Díaz Domínguez M, Iglesias Romero MC, et al. Algunos factores de riesgo a enfermedades cardiovasculares en un grupo de adultos supuestamente sanos. Rev Cub Aliment Nutri 1997;11:40-5. 18. Catelli WP. Papel de los nuevos factores de riesgo en la estimación del riesgo cardiovascular. Cardiovascular Risk Factors (sp. ed.) 1996;5(Supl 1):31-5. This article first appeared in Spanish in the Revista Cubana de Cardiología y Cirugía Cardiovascular 1999;13(1):8-12. |
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||